HindustanTimes Wed,17 Sep 2014

Sun Pharma posts Q1 profit on strong US sales

Reuters  Mumbai, August 13, 2014
First Published: 09:14 IST(13/8/2014) | Last Updated: 10:20 IST(13/8/2014)

Sun Pharmaceutical Industries Ltd, India's largest drugmaker by market value, reported a better-than-expected first-quarter profit, reflecting higher sales in its largest market, the United States.

April-June net profit was Rs. 13.91 billion ($227.73 million), compared with a net loss of Rs. 12.76 billion a year earlier. The prior-year period included a Rs. 25.17 billion provision for settlement of a patent infringement litigation.

Analysts on average had expected a profit of Rs 12.85 billion, according to data compiled by Thomson Reuters.

Net sales rose 12% to Rs. 39.36 billion, while sales in the United States, from where the company makes more than half its revenue, advanced 7%. Sun Pharma is in the process of gaining regulatory approvals for its $3.2 billion acquisition of loss-making rival Ranbaxy Laboratories Ltd from Japan's Daiichi Sankyo Ltd and expects to close the deal by December.

The company has got approvals for the deal from anti-competition authorities in all applicable markets excluding India and the United States, Sun Pharma said in a statement late on Tuesday.

more from Business

Mayank Pareek quits Maruti, tipped to join Tata Motors

In a major senior-level change, the head of marketing and sales at India’s largest passenger car maker Maruti Suzuki, Mayank Pareek, has quit the company after over two decades in the firm.
Most Popular
Copyright © 2014 HT Media Limited. All Rights Reserved